TFS
MRNA icon

TrustCore Financial Services’s Moderna MRNA Stock Holding History

TrustCore Financial Services’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$24.2K Hold
135
– – ﹤0.01% 573
2022
Q3 		$16K Hold
135
– – ﹤0.01% 659
2022
Q2 		$19K Sell
135
-2
-1% -$286 ﹤0.01% 650
2022
Q1 		$24K Sell
137
-28
-17% -$4.71K ﹤0.01% 620
2021
Q4 		$42K Sell
165
-70
-30% -$20.5K ﹤0.01% 474
2021
Q3 		$90K Buy
235
+135
+135% +$49.8K 0.01% 364
2021
Q2 		$23K Buy
+100
New +$17.9K ﹤0.01% 606
2020
Q3 		– Sell
-45
Closed -$3K – 893
2020
Q2 		$3K Sell
45
-155
-78% -$8.49K ﹤0.01% 769
2020
Q1 		$6K Buy
+200
New +$4.6K ﹤0.01% 672

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TrustCore Financial Services's MRNA Position: Q4 2022 in Review

TrustCore Financial Services held its Moderna (MRNA) position steady in Q4 2022 at 135 shares worth $24.2K. The position accounts for ﹤0.01% of the portfolio, ranked #573.

TrustCore Financial Services first reported a position in MRNA in Q1 2020 and has held it in 9 quarters since. The position peaked at $90K in Q3 2021. 1,071 funds tracked by Wall St. Rank hold MRNA as of Q4 2022.

  • TrustCore Financial Services held 135 shares of Moderna worth $24.2K as of Q4 2022.
  • TrustCore Financial Services left its Moderna share count unchanged in Q4 2022.
  • Moderna made up ﹤0.01% of TrustCore Financial Services's portfolio in Q4 2022, its #573 holding.
  • TrustCore Financial Services first reported a position in Moderna in Q1 2020 and has held it in 9 quarters since.
  • TrustCore Financial Services's Moderna position peaked at $90K in Q3 2021.
  • 1,071 funds tracked by Wall St. Rank held Moderna as of Q4 2022.

Based on TrustCore Financial Services's 13F filing for Q4 2022, filed 13 Feb 2023.